Target Gene/Pathway(薬物標的遺伝子/パスウェイリスト)
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z other
No. | KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * | KEGG DRUG * | DrugBank | 指定難病告示番号 * |
1 | Adrenergic signaling in cardiomyocytes |
1件: AGTR1 | D00400 | Valsartan | 6件: 57, 58, 66, 75, 218, 222 |
2 | AGE-RAGE signaling pathway in diabetic complications |
1件: AGTR1 | D00400 | Valsartan | 6件: 57, 58, 66, 75, 218, 222 |
3 | Aldosterone synthesis and secretion |
1件: AGTR1 | D00400 | Valsartan | 6件: 57, 58, 66, 75, 218, 222 |
4 | Aldosterone-regulated sodium reabsorption |
1件: NR3C2 | D00443 | Spironolactone | 6件: 58, 67, 86, 113, 218, 225 |
5 | AMPK signaling pathway |
1件: HMGCR | D00892 | Fluvastatin | 3件: 79, 218, 222 |
D07983 | |||||
6 | Apelin signaling pathway |
1件: AGTR1 | D00400 | Valsartan | 6件: 57, 58, 66, 75, 218, 222 |
7 | Bile secretion |
1件: HMGCR | D00892 | Fluvastatin | 3件: 79, 218, 222 |
D07983 | |||||
8 | Calcium signaling pathway |
1件: AGTR1 | D00400 | Valsartan | 6件: 57, 58, 66, 75, 218, 222 |
9 | cGMP-PKG signaling pathway |
1件: AGTR1 | D00400 | Valsartan | 6件: 57, 58, 66, 75, 218, 222 |
10 | Chagas disease (American trypanosomiasis) |
1件: ACE | D00620 | Benazepril | 3件: 57, 218, 224 |
D07499 | |||||
D00421 | Ramipril | 7件: 46, 49, 66, 67, 113, 218, 257 | |||
11 | Cortisol synthesis and secretion |
1件: AGTR1 | D00400 | Valsartan | 6件: 57, 58, 66, 75, 218, 222 |
12 | Cushing syndrome |
1件: AGTR1 | D00400 | Valsartan | 6件: 57, 58, 66, 75, 218, 222 |
13 | Endocrine and other factor-regulated calcium reabsorption |
1件: VDR | D00930 | Paricalcitol | 3件: 19, 66, 218 |
14 | Hypertrophic cardiomyopathy (HCM) |
1件: ACE | D00620 | Benazepril | 3件: 57, 218, 224 |
D07499 | |||||
D00421 | Ramipril | 7件: 46, 49, 66, 67, 113, 218, 257 | |||
15 | Metabolic pathways |
1件: HMGCR | D00892 | Fluvastatin | 3件: 79, 218, 222 |
D07983 | |||||
16 | Mineral absorption |
1件: VDR | D00930 | Paricalcitol | 3件: 19, 66, 218 |
17 | Neuroactive ligand-receptor interaction |
1件: AGTR1 | D00400 | Valsartan | 6件: 57, 58, 66, 75, 218, 222 |
18 | Parathyroid hormone synthesis, secretion and action |
1件: VDR | D00930 | Paricalcitol | 3件: 19, 66, 218 |
19 | Pathways in cancer |
1件: AGTR1 | D00400 | Valsartan | 6件: 57, 58, 66, 75, 218, 222 |
20 | Phospholipase D signaling pathway |
1件: AGTR1 | D00400 | Valsartan | 6件: 57, 58, 66, 75, 218, 222 |
21 | Renin secretion |
1件: ACE | D00620 | Benazepril | 3件: 57, 218, 224 |
D07499 | |||||
D00421 | Ramipril | 7件: 46, 49, 66, 67, 113, 218, 257 | |||
1件: AGTR1 | D00400 | Valsartan | 6件: 57, 58, 66, 75, 218, 222 | ||
22 | Renin-angiotensin system |
1件: ACE | D00620 | Benazepril | 3件: 57, 218, 224 |
D07499 | |||||
D00421 | Ramipril | 7件: 46, 49, 66, 67, 113, 218, 257 | |||
1件: AGTR1 | D00400 | Valsartan | 6件: 57, 58, 66, 75, 218, 222 | ||
23 | Terpenoid backbone biosynthesis |
1件: HMGCR | D00892 | Fluvastatin | 3件: 79, 218, 222 |
D07983 | |||||
24 | Tuberculosis |
1件: VDR | D00930 | Paricalcitol | 3件: 19, 66, 218 |
25 | Vascular smooth muscle contraction |
1件: AGTR1 | D00400 | Valsartan | 6件: 57, 58, 66, 75, 218, 222 |